Publication | Open Access
Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis
21
Citations
27
References
2021
Year
Perampanel was associated with a significant decline in ALSFRS-R score and was linked to worsening of the bulbar subscore in the 8 mg group.
| Year | Citations | |
|---|---|---|
Page 1
Page 1